Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Konka Pharmaceutical is a specialized pharmaceutical manufacturer based in Hangzhou, China, focusing on the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. The company is particularly recognized for its expertise in the metabolic disease space, producing widely used anti-diabetic medications such as Acarbose and Glimepiride. With a commitment to international quality standards, the firm operates GMP-certified facilities and supplies products to both the Chinese domestic market and various global regions. Their operations span from research and development to large-scale chemical synthesis and pharmaceutical formulation. As a subsidiary of the Konka Group, the company leverages significant industrial resources to maintain its position in the competitive generic drug market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Konka Pharmaceutical.